Multiple criteria decision analyisis for health technology assessment: scientific substantiation of criteria selection in Ukraine
Journal Title: Фармацевтичний журнал - Year 2017, Vol 5, Issue 5
Abstract
Multiple-criteria decision analysis (MCDA) is a framework where multiple criteria are being considered in a well-structured manner during the decision-making process. This methodology is becoming increasingly popular for aiding and supporting health-care decision making. Defining the criteria is a critical stage in the process as it forms the foundation of MCDA. Our aim was to review information sources on the application of MCDA in practice in the world and to analyze the criteria included in the MCDA models. Research objects were MCDA reports and models from PubMed database. Research methods were system and content analyzes, data synthesis, generalization, extrapolation, statistical. We reviewed scientific publications and official documents of existing or proposed MCDA models. We identified the criteria and assigned them into nine groups: Economics, Disease description, Intervention description, Health gain, Feasibility, Prevalence, Evidence quality, Social and ethical factors and Other criteria. We looked at MCDAs which are aimed to be used for Reimbursement or Investment Decisions (86%) and for Authorization Decisions (14%). Of the reviewed 25 MCDA models aimed to support reimbursement decisions only 1 lacks cost-related criteria, while 7 scoring systems lack social and ethical factors and 12 MCDAs don’t mention epidemiology or classification of target groups directly. We found that none of the reviewed MCDAs used for authorization decisions mentioned socioeconomic criteria. There is no direct connection between the number of criteria included in MCDA models intended to support reimbursement decisions and the GDP per capita figures of countries. It can be seen that the selection of criteria has no standardized approach yet and most of the existing or proposed MCDA models were conducted to be relevant for decision-makers in the particular decision problems. The MCDAs supporting reimbursement decisions considered more criteria and the majority of them included economics and societal factors while most MCDAs intended to support authorization decisions only focused on the potential health benefits and outcomes. The most MCDA models included in our research were built in high-income countries.
Authors and Affiliations
O. B. Piniazhko, Olha Zaliska
Keywords
Related Articles
- EP ID EP556070
- DOI 10.32352/0367-3057.5-6.17.03
- Views 54
- Downloads 0
Problems of scientific substantiation of extemporaneous formulations technologies and ways of its solution. P a r t IІ. Comparative analysis of modern pharmacopoeial requirements to technology and quality control of extemporaneous medicines
For today almost all countries of the world have State Pharmacopoeias, which are collections of standards for medicines and provide the basic principles of preparing dosage forms. They have legislative character, are man...
Synthesis and physicochemical research of some 2-((5-((theophylline-7'-yl)methyl)-4-R-4H-1,2,4-triazole-3-yl)thio)acetohydrazide ylidenderivatives
The rapid development pace of the pharmaceutical science constantly increases the demand for new kind of medicine featured with high biological activity and non-toxicity at the same time. Setting the aim to enlarge the a...
Research and contents nitrate contamination and elemental composition of medical plant and infusion of Polygonum hydropiper L., Polygonum persicaria L.
By now pharmacognostic analysis of medicinal plants includes only the determination of the content of active substances and the establishment of merchandising performance. But last years the constantly increase the level...
Study on domestic market of medicinal products of plant origin
The popularity of herbal remedies and medicines, with the participation of biologically active substances from plants is traditionally high. The annual increase of the domestic market for herbal remedies is due to the pr...
Development of composition and technology of hard gelatinous capsules of hepatoprotective and immunomodulating action
It is proven by modern clinical medicine, that there is violation of one from liver functions at it’s diseases, in particular synthesis of immunoproteins, that results in violation of humoral chain of immunity. Therefor...